Compassionate usePeptide
Compound 61523
Formula Pending
Molecular Mass
N/A
CAS Registry
AUTO-061523
Risk Class
HIGH
Last Audit
Mar 22, 2108
Research Abstract
Peptide candidate engineered for oncology adjuvant initiatives with automated dossier coverage.
Compound 61523 is a peptide asset inside peptide innovation track initiatives, optimized for oncology adjuvant and inflammation control.
The dossier currently sits in compassionate use with a high risk rating, meaning it is restricted to black-box teams with hardened compliance.
Supply records cite CAS AUTO-061523 with updates logged 2108-03-22.
Acquisition Protocol
Authorized research personnel may request deployment of this compound for laboratory analysis.
Primary Vectors
Oncology adjuvantInflammation control
Nomenclature
CX-61523Peptide Program 61523
Reference Material
- [1] Anubis Compound Registry • CAS AUTO-061523
- [2] Operations Pulse • Peptide innovation track
- [3] Risk Governance Ledger • HIGH clearance for COMPOUND-61523